Mid-market focused investment bank within SE Asia, Evolve Capital Advisory Pte Ltd

Evolve Capital Research

Mid-market focused investment bank within SE Asia

Evolve Capital Advisory Pte Ltd

Equity Bottom-Up

<ul>
<li>Since the Evolve Capital team began its foray into equity research in late 2024, we’ve been active in providing coverage within the small-mid cap space.</li>
<li>Singapore’s economy has outperformed expectations despite tariff-related headwinds. In light of this resilience, we remain constructive on Singapore’s prospects in the year ahead.  </li>
<li>In this note, we present our top ten picks within the SGX Catalist for 2026, which we have primarily selected through bottom-up analysis.</li>
</ul>


Since the Evolve Capital team began its foray into equity research in late 2024, we’ve been active in providing coverage within the small-mid cap space.
Singapore’s economy has outperformed expectations despite tariff-related headwinds. In light of this resilience, we remain constructive on Singapore’s prospects in the year ahead.  
In this note, we present our top ten picks within the SGX Catalist for 2026, which we have primarily selected through bottom-up analysis.


Dealing, Product Financing and Custody Services, Tickrs

Tickrs

Dealing, Product Financing and Custody Services

Tickrs Financial Singapore Pte Ltd (TFS) obtained Capital Markets Services (CMS) License from the Monetary Authority of Singapore (MAS) in 2022. Product offering include stock trading services across 10 global markets, futures trading, fixed income and wealth management products offering.

<ul><li>Regional Market Leader in Resilient Eye Care Segment: ISEC offers investors pure exposure to the ophthalmology healthcare niche, which enjoys resilient demand underpinned by aging demographics and rising chronic eye diseases.</li><li>Eye care is non-discretionary for many conditions (cataracts must be treated or vision is lost; diabetic retinopathy needs ongoing treatment, etc.), yielding stable patient volumes even in economic downturns.</li><li>During COVID-19, ISEC remained profitable each year, and post-pandemic it bounced back strongly as pent-up demand was served.</li></ul>

Regional Market Leader in Resilient Eye Care Segment: ISEC offers investors pure exposure to the ophthalmology healthcare niche, which enjoys resilient demand underpinned by aging demographics and rising chronic eye diseases.Eye care is non-discretionary for many conditions (cataracts must be treated or vision is lost; diabetic retinopathy needs ongoing treatment, etc.), yielding stable patient volumes even in economic downturns.During COVID-19, ISEC remained profitable each year, and post-pandemic it bounced back strongly as pent-up demand was served.

ISEC Healthcare Initiation : Clear Vision Ahead

SPDR Straits Times Index ETF / Equity Bottom-Up

<ul>
<li>The Evolve Capital team is excited to begin its foray into equity research, with the ability to offer a more diverse set of offerings alongside our corporate finance solutions.</li>
<li>As we initiate coverage on companies within the SGX space, Evolve Capital is committed to building a repository of insights, showcasing a diverse range of companies that embody growth potential. </li>
<li>We focus on identifying compelling investment stories that can attract local and international investors, aimed at uncovering promising investment opportunities in the Catalist market and offering value through our insights.</li>
</ul>


The Evolve Capital team is excited to begin its foray into equity research, with the ability to offer a more diverse set of offerings alongside our corporate finance solutions.
As we initiate coverage on companies within the SGX space, Evolve Capital is committed to building a repository of insights, showcasing a diverse range of companies that embody growth potential. 
We focus on identifying compelling investment stories that can attract local and international investors, aimed at uncovering promising investment opportunities in the Catalist market and offering value through our insights.


Unveiling Potential Gems Within the Catalist

SGX Market Strategist, Equity & Fixed Income, Singapore Exchange Ltd (SGX)

Geoff Howie

SGX Market Strategist, Equity & Fixed Income

Asia’s leading multi-asset exchange

Singapore Exchange Ltd (SGX)

Singapore Exchange is Asia’s leading and trusted market infrastructure, facilitating the exchange of capital and ideas to create value for people, businesses and economies. As a multi-asset exchange operating equity, fixed income and derivatives markets to the highest regulatory standards, SGX is a vertically integrated business that provides listing, trading, clearing, settlement, depository and data services.

With about 40% of listed companies and over 80% of listed bonds originating outside of Singapore as well as established linkages across the region and in Europe, SGX is Asia’s most international and connected exchange. Offering a full suite of derivatives products across Asian equity indices, commodities and currencies, SGX is the world’s most liquid international market for the benchmark equity indices of China, India, Japan and ASEAN.

As Asia’s pioneering central counterparty, SGX is globally recognised for its risk management and clearing capabilities, and was one of the first globally to adopt the Principles for Financial Market Infrastructure.

Headquartered in AAA-rated Singapore, SGX has over 800 employees including offices in Beijing, Chicago, Hong Kong, London, New York, Mumbai, San Francisco, Shanghai and Tokyo.

<ul><li>The FTSE ST Catalist Index’s top weights are Kimly, UnUsUaL, CNMC Goldmine Holdings, Alset International and ISEC Healthcare – covering a variety of industries, spanning across consumer, metals & mining and real estate operations with a combined market capitalisation of nearly S$950 million.</li><li>The FTSE ST Catalist index is a market capitalisation weighted index that tracks the performance of Catalist-listed, the SGX sponsor-supervised board for growth companies.</li><li>The five biggest index weights of the FTSE ST Catalist Index are Kimly, Unusual, CNMC Goldmine Holdings, Alset International and ISEC Healthcare.</li></ul>

The FTSE ST Catalist Index’s top weights are Kimly, UnUsUaL, CNMC Goldmine Holdings, Alset International and ISEC Healthcare – covering a variety of industries, spanning across consumer, metals & mining and real estate operations with a combined market capitalisation of nearly S$950 million.The FTSE ST Catalist index is a market capitalisation weighted index that tracks the performance of Catalist-listed, the SGX sponsor-supervised board for growth companies.The five biggest index weights of the FTSE ST Catalist Index are Kimly, Unusual, CNMC Goldmine Holdings, Alset International and ISEC Healthcare.

Five Stocks with the Most Impact on the FTSE ST Catalist Index

<ul><li>Wing Tai chairman Cheng Wai Keung continues building deemed interest Heavy lifting specialist Sin Heng Heavy Machinery also bought back 648,200 shares at an average price of S$0.49 per share.</li><li>Wing Tai Holdings chairman and managing director Cheng Wai Keung continued to build his deemed interest in the company, through his spouse Helen Chow acquiring shares.</li></ul>

Wing Tai chairman Cheng Wai Keung continues building deemed interest Heavy lifting specialist Sin Heng Heavy Machinery also bought back 648,200 shares at an average price of S$0.49 per share.Wing Tai Holdings chairman and managing director Cheng Wai Keung continued to build his deemed interest in the company, through his spouse Helen Chow acquiring shares.

Wing Tai Chair Cheng Wai Keung Continues Building Deemed Interest

Singapore

ISEC Healthcare is a leading regional provider of comprehensive medical eye care services through its ambulatory surgical centers. The company offers a full range of tertiary specialty services, including laser eye surgery (LASIK), vitreoretinal, orbital reconstruction, and complex corneal transplantation surgeries. ISEC Healthcare operates in Malaysia, Singapore, and Myanmar. It was founded in 2009 and is headquartered in Singapore.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

ISEC Healthcare (ISEC SP)

Catalist GEMs Poised to Shine (2026)

In this note, we present our top ten picks within the SGX Catalist for 2026, which we have primarily selected through bottom-up analysis.

Evolve Capital Advisory Pte Ltd

ISEC Healthcare Initiation : Clear Vision Ahead

Regional Market Leader in Resilient Eye Care Segment: ISEC offers investors pure exposure to the ophthalmology healthcare niche, which enjoys...

Tickrs

Unveiling Potential Gems Within the Catalist

The Evolve Capital team is excited to begin its foray into equity research, with the ability to offer a more diverse set of offerings alongside our...

Evolve Capital Advisory Pte Ltd

Five Stocks with the Most Impact on the FTSE ST Catalist Index

The FTSE ST Catalist Index’s top weights are Kimly, UnUsUaL, CNMC Goldmine Holdings, Alset International and ISEC Healthcare – covering a variety...

Singapore Exchange Ltd (SGX)

Wing Tai Chair Cheng Wai Keung Continues Building Deemed Interest

Wing Tai chairman Cheng Wai Keung continues building deemed interest Heavy lifting specialist Sin Heng Heavy Machinery also bought back 648,200...

Singapore Exchange Ltd (SGX)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)